Article Text

Download PDFPDF

A new cause for CA19.9 elevation: heavy tea consumption
  1. M Howaizi1,
  2. M Abboura1,
  3. C Krespine2,
  4. M-S Sbai-Idrissi3,
  5. O Marty4,
  6. M Djabbari-Sobhani5
  1. 1Service de Gastro-entérologie et Hépatologie, Groupement Hospitalier Eaubonne-Montmorency, Eaubonne 95602, France
  2. 2Service de Pneumologie, Groupement Hospitalier Eaubonne-Montmorency, Eaubonne 95602, France
  3. 3Service de Chirurgie Viscérale, Groupement Hospitalier Eaubonne-Montmorency, Eaubonne 95602, France
  4. 4Centre d’Exploration de l’Appareil Digestif, Clinique Gastrolouvre, Paris 75001, France
  5. 5Service de Radiologie, Groupement Hospitalier Eaubonne-Montmorency, Eaubonne 95602, France
  1. Correspondence to:
    M Howaizi, Service de Gastro-entérologie et Hépatologie, Groupement Hospitalier Eaubonne-Montmorency, 28 rue du Dr Roux, Eaubonne 95602 cedex, France;

Statistics from

Serum carbohydrate associated antigen (CA19.9) is a reliable tumour marker of biliopancreatic malignancies. A number of benign diseases are also known to be related to CA19.9 elevation. Here we report a case of markedly raised levels of CA19.9 associated with heavy tea consumption.

Case report

A 52 year old woman was referred to our unit for epigastric pain and anorexia of two months’ duration. She also complained of nausea and a 2 kg weight loss. Her past medical history was unremarkable. She was a non-smoker and denied alcohol abuse or medication intake but remarked on overconsumption of warm black tea for several months (1.5–2 litres/day). Physical examination was normal.

Laboratory data demonstrated normal ranges for electrolytes, liver function tests, blood count, urea, creatinin, C reactive protein, amylase, and lipase. Fasting blood glucose, triglycerides, cholesterol, and thyroid function tests were normal. Autoantibodies were negative. Serum CA19.9 was 1432 UI/ml (normal <37), and CEA was 2 ng/ml(normal <5).

Upper endoscopy, colonoscopy, and barium study of the small bowel showed normal results. Abdominal ultrasonography and computed tomography scan found mild enlargement of the body of the pancreas without hepatobiliary abnormalities. Endoscopic ultrasonography showed no pancreatic malignancy or biliary abnormalities. The pancreas was homogenous and mildly enlarged in the body without pathological significance.

Spirometry, chest x ray, bronchoscopy, and bronchoalveolar lavage fluid examination were normal.

The patient was advised to stop tea consumption. Four weeks later she became symptom free and gained the 2 kg weight loss. Another serum CA19.9 assay showed a considerable drop in levels to 42 UI/ml. A rechallenge test was then attempted. The patient restarted tea consumption as previously. Four weeks later CA19.9 increased to 745 UI/ml followed by a fall to 25 UI/ml one month after withdrawal. Follow up one year later revealed no clinical abnormalities. Abdominal and chest computed tomography scan were normal.


CA 19.9 (sialyl lewis-a) is a monosialoganglioside with small increases in a number of benign diseases, with highest levels in pancreatic adenocarcinoma, hepatocellular, and cholangiocellular cancer, and also in gastric, colorectal, and occasionally other cancers.1

Physiologically elevated concentrations are present in many secretions of healthy individuals with the Lewis a positive phenotype in contrast with low serum levels of CA19.9 in Lewis a negative individuals (7–10%).1

Among non-malignant causes, obstructive jaundice is frequently associated with increases in CA19.9. Relief of jaundice is often associated with a fall in CA19.9 in benign cases and mostly in patients with malignancy.2 Normal biliary epithelial cells secrete mucins carrying the epitope of CA 19.9. Unspecific elevation of CA 19.9 in serum reflects both inflammatory hypersecretion and leakage of biliary mucins into serum.3

In addition, there is a strong correlation between serum CA19.9 concentration and standard parameters of cholestasis; alkaline phosphatase and bilirubin during acute liver failure, acute hepatitis, and chronic liver diseases of any aetiology.4–6

Other benign causes of CA19.9 increases are shown in table 1. The common underlying mechanism for each is probably inflammatory hypersecretion of CA19.9 by normal epithelial cells.

Table 1

Non-malignant causes of CA19.9 elevation (medline research)

The constituent flavonoids of tea beverage are known to be potent antioxidants. It appears that the flavonoids impact on a wide range of molecular targets that influence cell growth and pathways of angiogenesis.7

In this case, the usual causes of CA19.9 elevation were ruled out before a link with the tea beverage was suspected. After tea consumption withdrawal, a dramatic improvement occurred and the patient became symptom free, suggesting the diagnosis of tea intoxication. At the same time, serum CA19.9 levels dropped and a positive rechallenge test proved the relationship between tea overconsumption and raised levels of CA19.9.

To our knowledge, this is the first reported case of markedly raised levels of CA19.9 associated with heavy tea consumption. The mechanism of this relation remains unclear. In addition, the epithelial tissue target involved in CA19.9 secretion by tea overuse is unknown. Individual susceptibility to abnormal CA19.9 secretion triggered by tea overconsumption could not be excluded.


View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.